These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 13573368)

  • 21. Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.
    Petit E; Langouet S; Akhdar H; Nicolas-Nicolaz C; Guillouzo A; Morel F
    Toxicol In Vitro; 2008 Apr; 22(3):632-42. PubMed ID: 18222062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease.
    ELLISON RR; KARNOFSKY DA; STERNBERG SS; MURPHY ML; BURCHENAL JH
    Cancer; 1954 Jul; 7(4):801-14. PubMed ID: 13172694
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.
    Gilissen LP; Bierau J; Derijks LJ; Bos LP; Hooymans PM; van Gennip A; Stockbrügger RW; Engels LG
    Aliment Pharmacol Ther; 2005 Oct; 22(7):605-11. PubMed ID: 16181300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
    PINE EK
    J Natl Cancer Inst; 1958 Nov; 21(5):973-84. PubMed ID: 13599021
    [No Abstract]   [Full Text] [Related]  

  • 25. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
    Goldenberg BA; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiopurine nucleotide synthesis in a 6-MP-resistant subline of the Ehrlich ascites carcinoma and growth inhibition by certain antimetabolites.
    PATERSON AR
    Can J Biochem Physiol; 1960 Oct; 38():1129-35. PubMed ID: 13733290
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of o-diazoacetyl-L-serine (azaserine) on the pregnancy of the dog; a preliminary report.
    FRIEDMAN MH
    J Am Vet Med Assoc; 1957 Feb; 130(4):159-62. PubMed ID: 13416078
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure-activity relationships among purines related to 6-mercaptopurine.
    CLARKE DA; ELION GB; HITCHINGS GH; STOCK CC
    Cancer Res; 1958 May; 18(4):445-56. PubMed ID: 13536996
    [No Abstract]   [Full Text] [Related]  

  • 29. Determination of mercaptopurine and its four metabolites by large-volume sample stacking with polarity switching in capillary electrophoresis.
    Wang CC; Chiou SS; Wu SM
    Electrophoresis; 2005 Jun; 26(13):2637-42. PubMed ID: 15934057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic studies of azaserine.
    EHRLICH J; ANDERSON LE; COFFEY GL; HILLEGAS AB; KNUDSEN MP; KOEPSELL HJ; KOHBERGER DL; OYAAS JE
    Nature; 1954 Jan; 173(4393):72. PubMed ID: 13132876
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and characterization of azaserine.
    BARTZ QR; ELDER CC; FROHARDT RP; FUSARI SA; HASKELL TH; JOHANNESSEN DW; RYDER A
    Nature; 1954 Jan; 173(4393):72-3. PubMed ID: 13132877
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azaserine assay with Kloeckera brevis.
    KOHBERGER DL; REILLY HC; COFFEY GL; HILLEGAS AB; EHRLICH J
    Antibiot Chemother (Northfield); 1955 Feb; 5(2):59-63. PubMed ID: 24543390
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzymatic degradation of azaserine.
    JACQUEZ JA; SHERMAN JH
    Cancer Res; 1962 Jan; 22():56-61. PubMed ID: 14450824
    [No Abstract]   [Full Text] [Related]  

  • 35. Observations on the action of azaserine in mammalian tissues.
    HENDERSON JF; LEPAGE GA; MCIVER FA
    Cancer Res; 1957 Jul; 17(6):609-12. PubMed ID: 13446847
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine.
    MOORE EC; LEPAGE GA
    Cancer Res; 1957 Sep; 17(8):804-8. PubMed ID: 13460988
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of azaserine against Plasmodium lophurae in chicks and attempts to antagonize this effect with metabolites.
    MCCARTHY DA; BAYLES A; THOMPSON PE
    J Parasitol; 1957 Jun; 43(3):283-90. PubMed ID: 13439465
    [No Abstract]   [Full Text] [Related]  

  • 38. Azaserine: pathological and pharmacological studies.
    STERNBERG SS; PHILIPS FS
    Cancer; 1957; 10(5):889-901. PubMed ID: 13472634
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of cancer inhibitor drugs on the take of Walker carcinosarcoma 256 in rats.
    MCDONALD GO; CRUZ EP; COLE WH
    Surg Forum; 1957; 7():486-9. PubMed ID: 13433422
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticancer nucleobase analogues 6-mercaptopurine and 6-thioguanine are novel substrates for equilibrative nucleoside transporter 2.
    Nagai K; Nagasawa K; Kihara Y; Okuda H; Fujimoto S
    Int J Pharm; 2007 Mar; 333(1-2):56-61. PubMed ID: 17088032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.